GalAhead™: A Proprietary GalNAc-RNAi Therapeutic Platform to Downregulate Single & Multiple Genes
Time: 9:00 am
day: Conference Day Two
Details:
• Introduction to GalAhead, Sirnaomics’ GalNAc-RNAi therapeutic platform
• Validation of technology in vivo and in vitro
• Progress report on GalAhead-based programs
